When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Cefaleia em salvas

最后审阅: 23 Aug 2025
最后更新: 02 Apr 2025

小结

定义

病史和体格检查

关键诊断因素

  • presença de fatores de risco
  • ataques repetidos de dor unilateral
  • curta duração
  • dor excruciante
  • lacrimejamento, rinorreia e síndrome de Horner parcial
  • agitação e inquietação
完整详情

危险因素

  • sexo masculino
  • história familiar
  • traumatismo cranioencefálico
  • tabagismo
  • consumo excessivo de álcool
完整详情

诊断性检查

首要检查

  • RNM de cérebro e hipófise sem e com contraste intravenoso
  • velocidade de hemossedimentação
完整详情

需考虑的检查

  • testes de função da hipófise
  • angiografia por ressonância magnética (ARM) de cabeça e pescoço com e sem contraste
  • tomografia computadorizada (TC) cranioencefálica
  • polissonografia
  • eletrocardiograma (ECG)
完整详情

治疗流程

急症处理

ataque agudo: sem doença cardiovascular, doença cerebrovascular ou hipertensão não controlada

ataque agudo: com doença cardiovascular, doença cerebrovascular ou hipertensão não controlada

持续性治疗

tratamento preventivo para cefaleia em salvas episódica

tratamento preventivo para cefaleia em salvas crônica

撰稿人

作者

Juliana VanderPluym, MD, FRCPC, FAHS

Associate Professor of Neurology

Department of Neurology

Mayo Clinic Arizona

Scottsdale

AZ

利益声明

JVP has received a research grant from Amgen. She has previously acted as a consultant for Teva and is on the editorial board of the American Migraine Foundation. JVP is a co-editor of the Headache section for Current Neurology and Neuroscience Reports.

Amaal J. Starling, MD

Associate Professor of Neurology

Department of Neurology

Mayo Clinic Arizona

Scottsdale

AZ

利益声明

AJS serves on the Board of Directors for the American Headache Society, the Alliance for Headache Disorders Advocacy, and the United Council for Neurologic Subspecialties. AJS has received consulting fees from AbbVie, Allergan, Amgen, Axsome Therapeutics, Eli Lilly & Company, Everyday Health, Impel, Lundbeck, Med-IQ, Medscape, Neurolief, Novartis, Satsuma, Teva, and Theranica. None are directly related to the topic of cluster headache.

Christoper C. Anderson, MD

Headache Medicine Fellow Physician

Mayo Clinic Arizona

Scottsdale

AZ

利益声明

CCA declares that he has no competing interests.

鸣谢

Dr Juliana VanderPluym, Dr Amaal J. Starling, and Dr Christopher C. Anderson would like to gratefully acknowledge Dr Sarah Miller, Dr Alok Tyagi, Dr Manjit S. Matharu, Dr Marc S. Husid, and Dr Davis L. Mellick, previous contributors to this topic.

利益声明

SM received an educational grant from St Jude Medical and Medtronic, and received payment for educational presentations from Allergan and Autonomic Technologies, Inc. AT was on advisory boards for Allergan and electroCore, and received organisational payments from eNeura, Allergan, and electroCore. MSM served on the advisory board for Allergan, St Jude Medical, and Medtronic, and received payment for the development of educational presentations from Allergan, MSD, Medtronic, and electroCore. MSH and DLM declare that they have no competing interests.

同行评议者

Mark W. Green, MD, FAAN

Director of Headache and Pain Medicine

Professor of Neurology, Anesthesiology, and Rehabilitation Medicine

Icahn School of Medicine at Mount Sinai

New York

NY

利益声明

MWG declares that he has no competing interests.

Anne Walling, MD

Professor

Family and Community Medicine

University of Kansas School of Medicine

Wichita

KS

利益声明

AW declares that she has no competing interests.

Christian Lampl, MD, PhD

Department Head

Department of Neurology and Pain Medicine

Konventhospital Barmherzige Brüder Linz

Linz

Austria

利益声明

CL declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Schindler EAD, Burish MJ. Recent advances in the diagnosis and management of cluster headache. BMJ. 2022 Mar 16;376:e059577. 摘要

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211.全文  摘要

American College of Radiology. ACR appropriateness criteria: headache. 2022 [internet publication].全文

Robbins MS, Starling AJ, Pringsheim TM, et al. Treatment of cluster headache: the American Headache Society evidence-based guidelines. Headache. 2016 Jul;56(7):1093-106.全文  摘要

Law S, Derry S, Moore RA. Triptans for acute cluster headache. Cochrane Database Syst Rev. 2013 Jul 17;(7):CD008042.全文  摘要

May A, Evers S, Goadsby PJ, et al. European Academy of Neurology guidelines on the treatment of cluster headache. Eur J Neurol. 2023 Oct;30(10):2955-79.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • 鉴别诊断

    • Enxaqueca
    • Hemicrania paroxística
    • Ataques de cefaleia de curta duração, unilateral, neuralgiforme com hiperemia conjuntival e lacrimejamento (SUNCT)
    更多 鉴别诊断
  • Diretrizes

    • Headaches in over 12s: diagnosis and management
    • European Academy of Neurology guidelines on the treatment of cluster headache
    更多 Diretrizes
  • Folhetos informativos para os pacientes

    Cefaleia em salvas: o que é?

    Cefaleia em salvas: quais tratamentos estão disponíveis?

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal